1-4 of 4
apolipoprotein l1
Close
Sort by
Journal Articles

Apolipoprotein L1 Genetic Variants Are Associated with Evidence of Early Kidney Injury in Sickle Cell Disease

Divya G Moodalbail, MD, Bonita Falkner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 985.
https://doi.org/10.1182/blood.V130.Suppl_1.985.985
Published: 2017
Journal Articles

RNA-Sequencing of Isolated Cell Populations Expressing Human APOL1 Risk Variants Reveals Molecular Correlates of Sickle Cell Nephropathy in Zebrafish Podocytes

Joseph L Bundy, PhD BS, Blair R Anderson, PhD, Ludmila Francescatto, PhD, Melanie E Garrett, MS, Karen L Soldano, BS, Marilyn J. Telen, MD, Erica E Davis, PhD, Allison E Ashley-Koch, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2236.
https://doi.org/10.1182/blood.V130.Suppl_1.2236.2236
Published: 2017
Journal Articles

Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model

Blair R. Anderson, Erica E. Davis, PhD, Marilyn J. Telen, MD, Allison E. Ashley-Koch, PhD
Journal: Blood
Blood (2014) 124 (21): 1374.
https://doi.org/10.1182/blood.V124.21.1374.1374
Published: 2014
Journal Articles

Vascular Endothelial Genes That Are Responsive to Tumor Necrosis Factor- In Vitro Are Expressed in Atherosclerotic Lesions, Including Inhibitor of Apoptosis Protein-1, Stannin, and Two Novel Genes

Anton J.G. Horrevoets, Ruud D. Fontijn, Anton Jan van Zonneveld, Carlie J.M. de Vries, Jan Wouter ten Cate, Hans Pannekoek
Journal: Blood
Blood (1999) 93 (10): 3418–3431.
https://doi.org/10.1182/blood.V93.10.3418.410k23_3418_3431
Published: 1999